Lista de obras -

A Longitudinal Study of Behavioral Deficits in an AβPP Transgenic Mouse Model of Alzheimer's Disease ⬇️

artículo científico publicado el 1 de enero de 2011

A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies

artículo científico publicado en 2015

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo ⬇️

artículo científico publicado en 2014

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy

artículo científico publicado en 2010

Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity

artículo científico publicado en 2010

Alzheimer's Disease: Recent Advances and Future Perspectives ⬇️

artículo científico publicado el 1 de enero de 2013

Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy

artículo científico publicado en 2014

Autophagy in dementias

artículo científico publicado en 2012

Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α-Synuclein ⬇️

artículo científico publicado el 9 de enero de 2013

Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease

artículo científico

Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

artículo científico publicado en 2012

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

artículo científico publicado en 2014

Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat.

artículo científico publicado en 2013

Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody

artículo científico publicado en 2012

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy ⬇️

artículo científico publicado el 13 de abril de 2012

Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy

artículo científico publicado en 2012

Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model

artículo científico publicado en 2012

Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies

artículo científico publicado en 2014

Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease

artículo científico publicado en 2009

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies

artículo científico publicado en 2009

Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy

artículo científico publicado en 2009

Multiple system atrophy: a clinical and neuropathological perspective ⬇️

artículo científico publicado el 29 de septiembre de 2011

Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease

artículo científico publicado en 2015

Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors

artículo científico publicado en 2010

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin

artículo científico publicado en 2009

Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy ⬇️

artículo científico publicado el 7 de marzo de 2012

Neuropathology of dementia with Lewy bodies in advanced age: A comparison with Alzheimer disease ⬇️

artículo científico publicado el 21 de septiembre de 2010

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease

artículo científico publicado en 2015

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

artículo científico publicado en 2015

Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling

artículo científico publicado en 2011

Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome

artículo científico publicado en 2008

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

artículo científico publicado en 2011

Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes

artículo científico publicado en 2014

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

artículo científico publicado en 2010

Recent advances in the development of immunotherapies for tauopathies ⬇️

artículo científico publicado el 21 de octubre de 2010

Reduced hypocretin (orexin) levels in dementia with Lewy bodies

artículo científico publicado en 2010

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

artículo científico publicado en 2014

Regional Comparison of the Neurogenic Effects of CNTF-Derived Peptides and Cerebrolysin in AβPP Transgenic Mice ⬇️

artículo científico publicado el 1 de enero de 2011

Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy

artículo científico publicado en 2008

Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.

artículo científico publicado en 2013

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy

artículo científico publicado en 2014

Lista de obras de

A Longitudinal Study of Behavioral Deficits in an AβPP Transgenic Mouse Model of Alzheimer's Disease ⬇️

A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo ⬇️

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy

Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity

Alzheimer's Disease: Recent Advances and Future Perspectives ⬇️

Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy

Autophagy in dementias

Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α-Synuclein ⬇️

Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease

Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat.

Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy ⬇️

Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy

Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model

Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies

Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies

Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy

Multiple system atrophy: a clinical and neuropathological perspective ⬇️

Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease

Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin

Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy ⬇️

Neuropathology of dementia with Lewy bodies in advanced age: A comparison with Alzheimer disease ⬇️

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling

Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

Recent advances in the development of immunotherapies for tauopathies ⬇️

Reduced hypocretin (orexin) levels in dementia with Lewy bodies

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

Regional Comparison of the Neurogenic Effects of CNTF-Derived Peptides and Cerebrolysin in AβPP Transgenic Mice ⬇️

Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy

Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy